Renal physiology of pregnancy
KL Cheung, RA Lafayette - Advances in chronic kidney disease, 2013 - Elsevier
Pregnancy involves remarkable orchestration of physiologic changes. The kidneys are central
players in the evolving hormonal milieu of pregnancy, responding and contributing to the …
players in the evolving hormonal milieu of pregnancy, responding and contributing to the …
[HTML][HTML] Anaritide in acute tubular necrosis
…, LS Weisberg, AZ Fenves, RA Lafayette… - … England Journal of …, 1997 - Mass Medical Soc
Background Atrial natriuretic peptide, a hormone synthesized by the cardiac atria, increases
the glomerular filtration rate by dilating afferent arterioles while constricting efferent arterioles…
the glomerular filtration rate by dilating afferent arterioles while constricting efferent arterioles…
[HTML][HTML] Rituximab or cyclosporine in the treatment of membranous nephropathy
…, SJ Barbour, BH Rovin, RA Lafayette… - … England Journal of …, 2019 - Mass Medical Soc
Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for …
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for …
[HTML][HTML] Podocytopenia and disease severity in IgA nephropathy
KV Lemley, RA Lafayette, M Safai, G Derby, K Blouch… - Kidney international, 2002 - Elsevier
Podocytopenia and disease severity in IgA nephropathy. Background IgA nephropathy is a
common form of progressive glomerular disease, associated with proliferation of mesangial …
common form of progressive glomerular disease, associated with proliferation of mesangial …
Renal artery stenosis in kidney transplants
FC Fervenza, RA Lafayette, EJ Alfrey… - American journal of kidney …, 1998 - ajkd.org
Transplant renal artery stenosis (TRAS) is an increasingly recognized complication of renal
transplantation, with a reported incidence of between 1% and 23%. The clinical features …
transplantation, with a reported incidence of between 1% and 23%. The clinical features …
[HTML][HTML] Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …
…, S Kaname, R Katafuchi, AR Kitching, RA Lafayette… - Kidney international, 2019 - Elsevier
The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies
Conference on glomerular diseases in November 2017. The conference focused on the …
Conference on glomerular diseases in November 2017. The conference focused on the …
[HTML][HTML] Nature of glomerular dysfunction in pre-eclampsia
RA Lafayette, M Druzin, R Sibley, G Derby, T Malik… - Kidney international, 1998 - Elsevier
… Author links open overlay panel Richard A. Lafayette , Maurice Druzin , Richard Sibley ,
Geraldine Derby , Tahira Malik , Phil Huie , Catherine Polhemus , William M. Deen , Bryan D. …
Geraldine Derby , Tahira Malik , Phil Huie , Catherine Polhemus , William M. Deen , Bryan D. …
[HTML][HTML] A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients …
…, JA Tumlin, A Saxena, R Saxena, RA Lafayette… - Kidney international, 2019 - Elsevier
Calcineurin inhibitors added to standard-of-care induction therapy for lupus nephritis (LN)
may increase complete renal remission (CRR) rates. The AURA-LV study tested the novel …
may increase complete renal remission (CRR) rates. The AURA-LV study tested the novel …
A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction
RA Lafayette, PA Canetta, BH Rovin… - Journal of the …, 2017 - journals.lww.com
IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of
immunosuppressive agents added to standard therapy, several recent studies have …
immunosuppressive agents added to standard therapy, several recent studies have …
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
GP Kaufman, SL Schrier, RA Lafayette… - Blood, The Journal …, 2017 - ashpublications.org
The majority of patients with immunoglobulin light chain amyloidosis (AL) fail to achieve a
complete response (CR) to standard light chain suppressive chemotherapy, and almost all …
complete response (CR) to standard light chain suppressive chemotherapy, and almost all …